Adaptive Biotechnologies (ADPT) Price to FCF (2019 - 2026)

Adaptive Biotechnologies has disclosed Price to FCF across 8 years of filings, most recently posting 449.87 for Q2 2026.

• In Q2 2026, Price to FCF fell 231.91% year-over-year to 449.87; the TTM figure through Jun 2026 stood at 141.96 (down 562.82% YoY), while the FY2025 annual figure was 51.02, down 469.96% from the prior year.
• Price to FCF came in at 449.87 for Q2 2026 at Adaptive Biotechnologies, down from 214.52 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 1759.96 in Q4 2025 to a low of 449.87 in Q2 2026.
• Average Price to FCF over 5 years is 15.44, with a median of 28.64 recorded in 2022.
• The largest YoY upside for Price to FCF was 2599.47% in 2025 against a maximum downside of 998.86% in 2025.
• Over 5 years, Price to FCF stood at 33.58 in 2022, then rose by 25.0% to 25.18 in 2023, then sank by 179.61% to 70.41 in 2024, then surged by 2599.47% to 1759.96 in 2025, then sank by 125.56% to 449.87 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 449.87 in Q2 2026, 214.52 in Q1 2026, and 1759.96 in Q4 2025.